MTOR and ovarian cancer: Further, the induction effects of mTOR inhibitor, rapamycin on cell cycle G1 phase arrest in ovarian cancer cells was impaired by AE2 overexpression, which suggested AE2 might promote cell cycle progression partially by activating mTOR/p70S6K1 pathway.